NuVasive Announces Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
NuVasive (NUVA) Tops Q2 EPS by 16c
July 28, 2021 4:55 PM EDTNuVasive (NASDAQ: NUVA) reported Q2 EPS of $0.60, $0.16 better than the analyst estimate of $0.44. Revenue for the quarter came in at $294.8 million versus the consensus estimate of $285.08 million.
"NuVasive continued to see the spine market stabilize throughout the second quarter, providing us the... More
